UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

OMB Number:  3235-0582

 

Expires:    April 30, 2009

 

Estimated average burden hours per response......14.4

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

H&Q Life Sciences Investors

(Exact name of registrant as specified in charter)

 

2 Liberty Square, 9th Floor, Boston, MA

 

02109

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward

H&Q Life Sciences Investors

2 Liberty Square, 9th Floor, Boston MA 02109

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617 772-8500

 

 

Date of fiscal year end:  September 30

 

 

Date of reporting period:  7/1/08-6/30/09

 

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 


 

Item 1. Proxy Voting Record.

 


 

HQL N-PX for the period July 1, 2008 to June 30, 2009

 

CUSIP

 

Symbol

Company Name

 

 

004225108

 

ACAD

ACADIA Pharmaceuticals Inc.

 

 

Meeting Date:

6/12/2009

 

Meeting Type:

Annual

Record Date:

4/13/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Uli Hacksell

 

For

 

For

 

Yes

 

Management

 

1

 

Elect director Torsten Rasmussen

 

For

 

For

 

Yes

 

Management

 

1

 

Elect director Alan Walton

 

For

 

For

 

Yes

 

Management

 

2

 

To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

For

 

Yes

 

Management

 

 

00817Y108

 

AET

Aetna Inc.

 

 

Meeting Date:

5/29/2009

 

Meeting Type:

Annual

Record Date:

3/27/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Frank M. Clark

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Betsy Z. Cohen

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Molly J. Coye, MD

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Roger N. Farah

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Barbara Hackman Franklin

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Jeffrey E. Garten

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Earl G. Graves

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Gerald Greenwald

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Ellen M. Hancock

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Richard J. Harrington

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Edward J. Ludwig

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Joseph P. Newhouse

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Ronald A. Williams

 

For

 

Yes

 

For

 

Management

 

2

 

Approval of indepdent registered public accounting firm

 

For

 

Yes

 

For

 

Management

 

3

 

Shareholder proposal on cumulative voting

 

Against

 

Yes

 

Against

 

Stockholder

 

4

 

Shareholder proposal on nominating a retired Aetna executive to the board

 

Against

 

Yes

 

Against

 

Stockholder

 

 

1


 

00826A109

 

AFFY

Affymax, Inc.

 

 

Meeting Date:

5/28/2009

 

Meeting Type:

Annual

Record Date:

3/31/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Ted W. Love, MD

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Arlene M. Morris

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Daniel K. Spiegelman

 

For

 

Yes

 

For

 

Management

 

2

 

To ratify the selection of Ernst & Young LLP as independent registered public accounting firm of Affymax for its fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

 

015351109

 

ALXN

Alexion Pharmaceuticals, Inc.

 

 

Meeting Date:

5/13/2009

 

Meeting Type:

Annual

Record Date:

3/24/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Leonard Bell

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Max Link

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Joseph A. Madri

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Larry L. Mathis

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director R. Douglas Norby

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Alvin S. Parven

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Ruedi E. Waeger

 

For

 

Yes

 

For

 

Management

 

2

 

Ratification of appointment by the board of directors of PricewaterhouseCoopers LLP as Alexion’s independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

 

 

016255101

 

ALGN

Align Technology, Inc.

 

 

Meeting Date:

5/21/2009

 

Meeting Type:

Annual

Record Date:

3/27/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director David E. Collins

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Joseph Lacob

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director C. Raymond Larkin, Jr.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director George J. Morrow

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Thomas M. Prescott

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Greg J. Santora

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Warren S. Thaler

 

For

 

Yes

 

For

 

Management

 

2

 

Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.’s independent registered public accountants for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

 

2


 

01642T108

 

ALKS

Alkermes, Inc.

 

 

Meeting Date:

10/7/2008

 

Meeting Type:

Annual

Record Date:

7/14/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Floyd E. Bloom

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Robert A. Breyer

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Geraldine Henwood

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Paul J. Mitchell

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Richard F. Pops

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Alexander Rich

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Dvid A. Broeckert

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Mark B. Skaletsky

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Michael A. Wall

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director David W. Anstice

 

For

 

Yes

 

For

 

Management

 

2

 

To approve the Alkermes 2008 stock option and incentive plan

 

For

 

Yes

 

Against

 

Management

 

3

 

To ratify PricewaterhouseCoopers LLP as the company’s independent registered public accountant for fiscal year 2009

 

For

 

Yes

 

For

 

Management

 

 

02043Q107

 

ALNY

Alnylam Pharmaceuticals, Inc.

 

 

Meeting Date:

6/11/2009

 

Meeting Type:

Annual

Record Date:

4/15/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director John K. Clarke

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Vicki L. Sato, Ph.D.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director James L. Vincent

 

For

 

Yes

 

For

 

Management

 

2

 

To approve the amendment and restatement of Alnylam’s 2004 stock incentive plan

 

For

 

Yes

 

For

 

Management

 

3

 

To approve the adoption of Alnylam’s 2009 stock incentive plan

 

For

 

Yes

 

For

 

Management

 

4

 

To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam’s independent auditors for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

 

3


 

031162100

 

AMGN

Amgen Inc.

 

 

Meeting Date:

5/6/2009

 

Meeting Type:

Annual

Record Date:

3/9/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Dr. David Baltimore

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Frank J. Biondi, Jr.

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Francois de Carbonnel

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Jerry D. Choate

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Dr. Vance D. Coffman

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Frederick W. Gluck

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Frank C. Herringer

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Dr. Gilbert S. Omenn

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Judity C. Pelham

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Adm. J. Paul Reason, UsN

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Leonard D. Schaeffer

 

For

 

Yes

 

For

 

Management

 

1

 

Elect director Kevin W. Sharer

 

For

 

Yes

 

For

 

Management

 

2

 

To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

3

 

To approve the proposed 2009 equity incentive plan, which authorizes the issuance of 100,000,000 shares

 

For

 

Yes

 

For

 

Management

 

4

 

To approve the proposed amendment to our restated certificate of incorporation, as amended, which reduces the sixty-six and two-thirds percent voting requirement to a simple majority voting requirement for approval of certain business combinations

 

For

 

Yes

 

For

 

Management

 

5

 

Stockholder proposal #1 to amend our bylaws to permit 10% of our outstanding common stock the ability to call special meetings

 

Against

 

Yes

 

Against

 

Stockholder

 

5

 

Stockholder proposal #2 to change our jurisdiction of incorporation from Delaware to North Dakota

 

Against

 

Yes

 

Against

 

Stockholder

 

 

4


 

032346108

 

AMLN

Amylin Pharmaceuticals, Inc.

 

 

Meeting Date:

5/27/2009

 

Meeting Type:

Annual - Contested

Record Date:

4/8/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director M. Kathleen Behrens

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect director Charles M. Fleischman

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect director Jay Sherwood

 

Unkown

 

Yes

 

Withhold

 

Opposition

 

1

 

Elect director Dr. A.J. Denner

 

Unkown

 

Yes

 

Withhold

 

Opposition

 

1

 

Elect director Dr. T.F. Deuel

 

Unkown

 

Yes

 

Withhold

 

Opposition

 

1

 

Elect director Adrian Adams

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect director Teresa Beck

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect director D.M. Bradbury

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect director Paul N. Clark

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect director Paulo F. Costa

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect director Karin Eastham

 

Unkown

 

Yes

 

For

 

Opposition

 

1

 

Elect directo Jay S. Skyler

 

Unkown

 

Yes

 

For

 

Opposition

 

2

 

Proposal to adopt the company’s 2009 equity incentive plan as described in the proxy statement

 

Unkown

 

Yes

 

For

 

Opposition

 

3

 

2001 employee stock purchase plan proposal as described in the proxy statement

 

Unkown

 

Yes

 

For

 

Opposition

 

4

 

Proposal to ratify Ernst & Young LLP as the independent public registered accounting firm for Amylin for the year ending December 31, 2009

 

Unkown

 

Yes

 

For

 

Opposition

 

5

 

Icahn reincorporation proposal as described in the proxy statement

 

Unkown

 

Yes

 

Against

 

Opposition

 

 

032346108

 

AMLN

Amylin Pharmaceuticals, Inc.

 

 

Meeting Date:

5/27/2009

 

Meeting Type:

Annual - Contested

Record Date:

4/8/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Adrian Adams

 

For

 

No

 

None

 

Management

 

1

 

Elect director Steven R. Altman

 

For

 

No

 

None

 

Management

 

1

 

Elect director Teresa Beck

 

For

 

No

 

None

 

Management

 

1

 

Elect director Daniel M. Bradbury

 

For

 

No

 

None

 

Management

 

1

 

Elect director Paul N. Clark

 

For

 

No

 

None

 

Management

 

1

 

Elect director Joseph C. Cook, Jr.

 

For

 

No

 

None

 

Management

 

1

 

Elect director Paulo F. Costa

 

For

 

No

 

None

 

Management

 

1

 

Elect director Karin Eastham

 

For

 

No

 

None

 

Management

 

1

 

Elect director James R. Gavin III

 

For

 

No

 

None

 

Management

 

1

 

Elect director Jay S. Skyler

 

For

 

No

 

None

 

Management

 

1

 

Elect director Joseph P. Sullivan

 

For

 

No

 

None

 

Management

 

1

 

Elect director James N. Wilson

 

For

 

No

 

None

 

Management

 

2

 

To approve the company’s 2009 equity incentive plan

 

For

 

No

 

None

 

Management

 

3 

 

To approve an increase of 1,500,000 shares in the aggregate number of shares of the company’s common stock authorized for issuance under the company’s 2001 employee stock purchase plan

 

For

 

No

 

None

 

Management

 

4

 

To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the company for its fiscal year ending December 31, 2009

 

For

 

No

 

None

 

Management

 

5

 

Stockholder proposal to change the company’s jurisdiction of incorporation from Delaware to North Dakota

 

Against

 

No

 

None

 

Stockholder

 

 

5


 

032346108

 

AMLN

Amylin Pharmaceuticals, Inc.

 

 

Meeting Date:

5/27/2009

 

Meeting Type:

Annual - Contested

Record Date:

4/8/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Alexander J. Denner

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Thomas F. Deuel

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director M.K. Behrens

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director C.M. Fleischman

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Jay Sherwood

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Adrian Adams

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Teresa Beck

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director D.M. Bradbury

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Paul N. Clark

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Paulo F. Costa

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Karin Eastham

 

Unkown

 

No

 

None

 

Opposition

 

1

 

Elect director Jay S. Skyler

 

Unkown

 

No

 

None

 

Opposition

 

2

 

Amylin’s equity incentive plan

 

Unkown

 

No

 

None

 

Opposition

 

3

 

Amendment to the 2001 employee stock purchase plan

 

Unkown

 

No

 

None

 

Opposition

 

4

 

Ratification of appointment of independent registered public accounting firm

 

Unkown

 

No

 

None

 

Opposition

 

5

 

North Dakota reincorporation proposal

 

Unkown

 

No

 

None

 

Stockholder

 

 

038149100

 

ABI

Applied Biosystems Inc.

 

 

Meeting Date:

10/16/2008

 

Meeting Type:

Special

Record Date:

9/5/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Approve and adopt the agreement and plan of merger, as amended, by and among Invitrogen Corporation, Atom Acquisition, LLC, and Applied Biosystems Inc., as such agreement may be amended from time to time, and to approve the merger of Applied Biosystems Inc. with and into Atom Acquisition, LLC, all as more fully described in the proxy statement

 

For

 

Yes

 

For

 

Management

 

2

 

To adjourn the Applied Biosystems Inc. special meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes for the foregoing proposal

 

For

 

Yes

 

For

 

Management

 

 

04744L106

 

ATHX

Athersys, Inc.

 

 

Meeting Date:

6/18/2009

 

Meeting Type:

Annual

Record Date:

4/24/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director Gil Van Bokkelen

 

For

 

No

 

None

 

Management

 

1

 

Elect director Jordan S. Davis

 

For

 

No

 

None

 

Management

 

1

 

Elect director John J. Harrington

 

For

 

No

 

None

 

Management

 

1

 

Elect director Floyed D. Loop

 

For

 

No

 

None

 

Management

 

1

 

Elect director George M. Milne, Jr.

 

For

 

No

 

None

 

Management

 

1

 

Elect director William C. Mulligan

 

For

 

No

 

None

 

Management

 

1

 

Elect director Lorin J. Randall

 

For

 

No

 

None

 

Management

 

1

 

Elect director Michael Sheffery

 

For

 

No

 

None

 

Management

 

2

 

Ratification for Ernst & Young LLP as auditors

 

For

 

No

 

None

 

Management

 

 

6


 

05334D107

 

AUXL

Auxilium Pharmaceuticals, Inc.

 

 

Meeting Date:

6/10/2009

 

Meeting Type:

Annual

Record Date:

4/16/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Rolf A. Classon

 

For

 

Yes

 

For

 

Management

1

 

Elect director Al Altomari

 

For

 

Yes

 

For

 

Management

1

 

Elect director Armando Anido

 

For

 

Yes

 

For

 

Management

1

 

Elect director Edwin A. Bescherer, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director P.O. Chambon, MD, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Oliver S. Fetzer, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Renato Fuchs, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dennis Langer, MD, JD

 

For

 

Yes

 

For

 

Management

1

 

Elect director William T. McKee

 

For

 

Yes

 

For

 

Management

2

 

Approve amendment and restatement of Auxilium Pharmaceuticals, Inc. 2004 equity compensation plan to increase number of shares of company common stock authorized for issuance under the plan by 2,650,000 shares from 8,000,000 to 10,650,000 shares, subject to limitation that of those 2,650,000 shares only 700,000 shares may be issued pursuant to stock awards, stock units

 

For

 

Yes

 

For

 

Management

4

 

To ratify the selection by the audit and compliance committee of the company’s board of directors of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

05346P106

 

AVRX

Avalon Pharmaceuticals, Inc.

 

 

Meeting Date:

5/28/2009

 

Meeting Type:

Special

Record Date:

4/13/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To consider and vote upon a proposal to adopt the agreement and plan of merger and reorganization, dated as of October 27, 2008, as amended, by and among Clinical Data, Inc., API Acquisition Sub II, LLC, and Avalon Pharmaceuticals, Inc., pursuant to which API will merge with and into Avalon, with Avalon being the surviving corporation

 

For

 

Yes

 

For

 

Management

2

 

To consider and vote upon a proposal to adjourn the special meeting to a later date or time, if necessary or appropriate, to solicit additional proxies in the event there are insufficient votes at the time of the special meeting to adopt the merger agreement

 

For

 

Yes

 

For

 

Management

 

7


 

068306109

 

BRL

Barr Pharmaceuticals, Inc.

 

 

Meeting Date:

11/21/2008

 

Meeting Type:

Special

Record Date:

10/10/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Adoption of the agreement and plan of merger, dated as of July 18, 2008 by and among Barr Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Ltd. and Boron Acquisition Corp., as it may be amended from time to time

 

For

 

Yes

 

For

 

Management

2

 

Approval of the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to adopt the agreement and plan of merger referred to in proposal 1

 

For

 

Yes

 

For

 

Management

 

09062X103

 

BIIB

Biogen Idec

 

 

Meeting Date:

6/3/2009

 

Meeting Type:

Annual - Contested

Record Date:

4/6/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Lawrence C. Best

 

For

 

Yes

 

For

 

Management

1

 

Elect director Alan B. Glassberg

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert W. Pangia

 

For

 

Yes

 

For

 

Management

1

 

Elect director William D. Young

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

3

 

To approve amendments to the company’s bylaws to change the voting standard for the election of directors in uncontested elections from a plurality to a majority standard

 

For

 

Yes

 

For

 

Management

4

 

Shareholder proposal to amend the company’s bylaws to fix the size of the board at 13 members and remove the board’s ability to change the size of the board

 

Against

 

Yes

 

Against

 

Stockholder

5

 

Shareholder proposal that the company reincorporate from Deleware to North Dakota and elect to be subject to the North Dakota publicly traded corporations act

 

Against

 

Yes

 

Against

 

Stockholder

 

8


 

09062X103

 

BIIB

Biogen Idec

 

 

Meeting Date:

6/3/2009

 

Meeting Type:

Annual - Contested

Record Date:

4/6/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Alexander J. Denner

 

Against

 

No

 

None

 

Opposition

1

 

Elect director Richard C. Mulligan

 

Against

 

No

 

None

 

Opposition

1

 

Elect director Thomas F. Deuel

 

Against

 

No

 

None

 

Opposition

1

 

Elect director David Sidransky

 

Against

 

No

 

None

 

Opposition

2

 

Approval of the Icahn bylaws amendments

 

Against

 

No

 

None

 

Opposition

3

 

Approval of the North Dakota Reincorporation resolution

 

Against

 

No

 

None

 

Opposition

4

 

Ratification of independent registered public accounting firm

 

Against

 

No

 

None

 

Opposition

5

 

Approval of the Biogen bylaw amendment

 

Against

 

No

 

None

 

Opposition

 

14159L103

 

BEAT

CardioNet, Inc.

 

 

Meeting Date:

10/23/2008

 

Meeting Type:

Annual

Record Date:

9/10/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect Director Ronald A. Ahrens

 

For

 

Yes

 

For

 

Management

1

 

Elect Fred Middleton

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the Audit Committee of our board of directors of Ernst & Young LLP as our independent auditors for the fiscal year ending December 31, 2008

 

For

 

Yes

 

For

 

Management

 

14159L103

 

BEAT

CardioNet, Inc.

 

 

Meeting Date:

5/8/2009

 

Meeting Type:

Annual

Record Date:

3/16/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Randy H. Thurman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kirk E. Gorman

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as the independent auditors for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

3

 

To approve an amendment to the CardioNet, Inc. 2008 non-employee directors’ stock option plan and all outstanding options granted thereunder to date to extend the post-termination exercise period for vested options from three months following director’s termination of service to the remainder of the option term in effect at the time of the director’s termination of service

 

For

 

Yes

 

Against

 

Management

 

9


 

14888B103

 

CHSI

Catalyst Health Solutions Inc.

 

 

Meeting Date:

6/1/2009

 

Meeting Type:

Annual

Record Date:

4/3/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Steven B. Epstein

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael R. McDonnell

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dale B. Wolf

 

For

 

Yes

 

For

 

Management

2

 

The approval of reservation of additional 100,000 shares of company stock for issuance under the company’s 2004 employee stock purchase plan

 

For

 

Yes

 

For

 

Management

3

 

The ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants of Catalyst Health Solutions, Inc. for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

151020104

 

CELG

Celgene Corporation

 

 

Meeting Date:

6/17/2009

 

Meeting Type:

Annual

Record Date:

4/21/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Sol J. Barer, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Hugin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael D. Casey

 

For

 

Yes

 

For

 

Management

1

 

Elect director Rodman L. Drake

 

For

 

Yes

 

For

 

Management

1

 

Elect director A.H. Hayes, Jr., MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gilla Kaplan, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director James J. Loughlin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ernest Mario, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Walter L. Robb, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of KPMG LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

3

 

Approval of an amendment and restatement of the company’s 2008 stock incentive plan

 

For

 

Yes

 

For

 

Management

4

 

Stockholder proposal regarding the voting standard for director elections

 

Against

 

Yes

 

Against

 

Stockholder

 

10


 

156708109

 

CEPH

Cephalon, Inc.

 

 

Meeting Date:

5/12/2009

 

Meeting Type:

Annual

Record Date:

3/17/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director F. Baldino, Jr., Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director William P. Egan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Martyn D. Greenacre

 

For

 

Yes

 

For

 

Management

1

 

Elect director Vaughn M. Kailian

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kevin E. Moley

 

For

 

Yes

 

For

 

Management

1

 

Elect director C.A. Sanders, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gail R. Wilensky, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dennis L. Winger

 

For

 

Yes

 

For

 

Management

2

 

Approval of amendment to the 2004 equity compensation plan increasing the number of shares authorized for issuance

 

For

 

Yes

 

For

 

Management

3

 

Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants for the year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

N/A

 

N/A

Concentric Medical, Inc.

 

 

Action by Written Consent:

12/15/2008

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of amended and restated certificate of incorporation

 

For

 

Yes

 

For

 

Management

2

 

Approval of issuance of preferred stock

 

For

 

Yes

 

For

 

Management

3

 

Approval of waiver of right of first refusal

 

For

 

Yes

 

For

 

Management

4

 

Approval of increase to stock plan

 

For

 

Yes

 

For

 

Management

5

 

Approval of indemnification agreements

 

For

 

Yes

 

For

 

Management

6

 

Omnibus resolution

 

For

 

Yes

 

For

 

Management

 

21924P103

 

CRTX

Cornerstone Therapeutics Inc.

 

 

Meeting Date:

5/28/2009

 

Meeting Type:

Annual

Record Date:

3/30/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Christophe Codeanne

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael Enright

 

For

 

Yes

 

For

 

Management

2

 

To approve the company’s 2004 stock incentive plan, as amended and restated, restated, to among other things, increase the number of shares authorized for issuance thereunder and increase the number of shares that may be granted to a participant in a calendar year

 

For

 

Yes

 

Against

 

Management

3

 

To ratify the selection by the audit committee of Grant Thornton LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

11


 

22674T105

 

CRTX

Critical Therapeutics, Inc.

 

 

Meeting Date:

10/31/2008

 

Meeting Type:

Special

Record Date:

9/29/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the issuance of Critical Therapeutics’ common stock pursuant to the agreement and plan of merger, dated as of May 1, 2008, by and among Critical Therapeutics, Neptune Acquisition Corp., a wholly owned subsidiary of Critical Therapeutics, and Cornerstone Biopharma Holdings, Inc.

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to Critical Therapeutics certificate of incorporation to effect a reverse stock split of Critical Therapeutcs’ common stock

 

For

 

Yes

 

For

 

Management

3

 

To approve an amendment to Critical Therapeutics’ certificate of incorporation to change the name of Critical Therapeutics to “Cornerstone Therapeutics Inc.”

 

For

 

Yes

 

For

 

Management

4

 

To consider and vote upon an adjournment of the special meeting, if necessary if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of proposals 1, 2 and 3

 

For

 

Yes

 

For

 

Management

 

222083107

 

CGRB

Cougar Biotechnology, Inc.

 

 

Meeting Date:

10/28/2008

 

Meeting Type:

Special

Record Date:

9/9/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of proposed amendments to the company’s 2003 stock option plan as described in the accompanying proxy statement

 

For

 

Yes

 

For

 

Management

 

229678107

 

CBST

Cubist Pharmaceuticals, Inc.

 

 

Meeting Date:

6/4/2009

 

Meeting Type:

Annual

Record Date:

4/9/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Kenneth Bate

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nancy Hutson

 

For

 

Yes

 

For

 

Management

1

 

Elect director Martin Soeters

 

For

 

Yes

 

For

 

Management

2

 

A proposal to amend the amended and restated 1997 employee stock purchase plan, or ESPP, to increase the number of shares issuable under the ESPP by 500,000

 

For

 

Yes

 

For

 

Management

3

 

A proposal to amend out amended and restated 2002 directors’ equity incentive plan to extend the term of the directors’ plan by 3 years and to increase the number of shares issuable under the directors’ plan by 400,000

 

For

 

Yes

 

For

 

Management

4

 

A proposal to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

12


 

278856109

 

ECLP

Eclipsys Corp.

 

 

Meeting Date:

5/13/2009

 

Meeting Type:

Annual

Record Date:

3/20/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director John T. Casey

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jay B. Pieper

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of PricewaterhouseCoopers LLP by the board of directors as the company’s independent registered public accounting firm for the current fiscal year

 

For

 

Yes

 

For

 

Management

 

285192100

 

MELA

Electro-Optical Sciences, Inc.

 

 

Meeting Date:

5/22/2009

 

Meeting Type:

Annual

Record Date:

4/9/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Joseph V. Gulfo, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director Breaux Castleman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Sidney Braginsky

 

For

 

Yes

 

For

 

Management

1

 

Elect director George C. Chryssis

 

For

 

Yes

 

For

 

Management

1

 

Elect director Martin D. Cleary

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dan W. Lufkin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gerald Wagner, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

To ratify selection of Eisner LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

3

 

To approve a plan amendment to increase by 1,500,000 the aggregate number of shares of common shares that are available under the 2005 stock incentive plan

 

For

 

Yes

 

For

 

Management

 

N/A

 

N/A

Eleme Medical, Inc.

 

 

Action by Written Consent:

8/1/2008

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of amendment to certificate of incorporation

 

For

 

Yes

 

For

 

Management

2

 

Approval of general authorization

 

For

 

Yes

 

For

 

Management

 

13


 

30161Q104

 

EXEL

Exelixis, Inc.

 

 

Meeting Date:

5/13/2009

 

Meeting Type:

Annual

Record Date:

3/16/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Charles Cohen, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director George Poste, DVM, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jack L. Wyszomierski

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP as Exelixis’ independent registered public accounting firm for the fiscal year ending January 1, 2010

 

For

 

Yes

 

For

 

Management

3

 

To approve an amendment to the Exelixis, Inc. 2000 employee stock purchase plan to increase the number of shares of common stock reserved for issuance under the 2000 employee stock purchase plan by 5,000,000 shares

 

For

 

Yes

 

Against

 

Management

4

 

To approve the amendment and restatement of the Exelixis, Inc. 2000 equity incentive plan

 

For

 

Yes

 

Against

 

Management

5

 

To approve a proposed exchange of certain outstanding stock options for a reduced number of replacement stock options to be granted under the 2000 equity incentive plan with an exercise price equal to the fair market value of Exelixis common stock at the time of the exchange

 

For

 

Yes

 

For

 

Management

 

N/A

 

N/A

FlowCardia, Inc.

 

 

Action by Written Consent:

3/3/2009

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of amendment to amend and restated equity incentive plan

 

For

 

No

 

None

 

Management

2

 

General authority and ratification

 

For

 

No

 

None

 

Management

 

345838106

 

FRX

Forest Laboratories, Inc.

 

 

Meeting Date:

8/11/2008

 

Meeting Type:

Annual

Record Date:

6/19/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Howard Solomon

 

For

 

Yes

 

For

 

Management

1

 

Elect director L.S. Olanoff, MD, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nesli Basgoz, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director William J. Candee, III

 

For

 

Yes

 

For

 

Management

1

 

Elect director George S. Cohan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dan L. Goldwasser

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kenneth E. Goodman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Lester B. Salans, MD

 

For

 

Yes

 

For

 

Management

2

 

Adoption of the amended and restated certificate of incorporation

 

For

 

Yes

 

For

 

Management

3

 

Ratification of BDO Seidman, LLP as independent registered public acocunting firm

 

For

 

Yes

 

For

 

Management

 

14


 

372917104

 

GENZ

Genzyme Corporation

 

 

Meeting Date:

5/21/2009

 

Meeting Type:

Annual

Record Date:

3/31/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Douglas A. Berthiaume

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gail K. Boudreaux

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Carpenter

 

For

 

Yes

 

For

 

Management

1

 

Elect director Charles L. Cooney

 

For

 

Yes

 

For

 

Management

1

 

Elect director Victor J. Dzau

 

For

 

Yes

 

For

 

Management

1

 

Elect director Senator Connie Mack III

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard F. Syron

 

For

 

Yes

 

For

 

Management

1

 

Elect director Henri A. Termeer

 

For

 

Yes

 

For

 

Management

2

 

A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock available for issuance under the plan by 2,500,000 shares

 

For

 

Yes

 

For

 

Management

3

 

A proposal to approve the 2009 employee stock purchase plan

 

For

 

Yes

 

For

 

Management

4

 

A proposal to ratify the audit committee’s selection of independent auditors for 2009 (PricewaterhouseCoopers LLP)

 

For

 

Yes

 

For

 

Management

 

375558103

 

GILD

Gilead Sciences, Inc.

 

 

Meeting Date:

5/6/2009

 

Meeting Type:

Annual

Record Date:

3/9/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Paul Berg

 

For

 

Yes

 

For

 

Management

1

 

Elect director John F. Cogan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Etienne F. Davignon

 

For

 

Yes

 

For

 

Management

1

 

Elect director James M. Denny

 

For

 

Yes

 

For

 

Management

1

 

Elect director Carla A. Hills

 

For

 

Yes

 

For

 

Management

1

 

Elect director John W. Madigan

 

For

 

Yes

 

For

 

Management

1

 

Elect director John C. Martin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gordon E. Moore

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nicholas G. Moore

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard J. Whitley

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gayle E. Wilson

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Ernst & Young LLP by the audit committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

3

 

To approve an amendment to Gilead’s 2004 equity incentive plan

 

For

 

Yes

 

For

 

Management

 

15


 

436440101

 

HOLX

Hologic, Inc.

 

 

Meeting Date:

3/4/2009

 

Meeting Type:

Annual

Record Date:

1/16/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director John W. Cumming

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert A. Cascella

 

For

 

Yes

 

For

 

Management

1

 

Elect director David R. Lavance, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nancy L. Leaming

 

For

 

Yes

 

For

 

Management

1

 

Elect director Lawrence M. Levy

 

For

 

Yes

 

For

 

Management

1

 

Elect director Glenn P. Muir

 

For

 

Yes

 

For

 

Management

1

 

Elect director Elaine S. Ullian

 

For

 

Yes

 

For

 

Management

1

 

Elect director Sally W. Crawford

 

For

 

Yes

 

For

 

Management

1

 

Elect director Wayne Wilson

 

For

 

Yes

 

For

 

Management

2

 

To consider and act upon a stock option exchange program for eligible employees

 

For

 

Yes

 

For

 

Management

3

 

To consider and act upon the adjournment of the annual meeting, including if necessary, to solicit additional proxies in favor of the foregoing proposals, as described in the accompanying proxy statement

 

For

 

Yes

 

For

 

Management

 

45103T107

 

ICLR

Icon plc

 

 

Meeting Date:

7/21/2008

 

Meeting Type:

Annual

Record Date:

N/A

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To receive the accounts and reports

 

For

 

Yes

 

For

 

Management

2

 

To re-elect Dr. John Climax

 

For

 

Yes

 

For

 

Management

3

 

To re-elect Edward Roberts

 

For

 

Yes

 

For

 

Management

4

 

To re-elect Prof. Dermot Kelleher

 

For

 

Yes

 

For

 

Management

5

 

To authorise the fixing of the Auditor’s renumeration

 

For

 

Yes

 

For

 

Management

6

 

To approve the 2008 employee restricted share unit plan

 

For

 

Yes

 

Against

 

Management

7

 

To approve the employee share option plan 2008

 

For

 

Yes

 

Against

 

Management

8

 

Tp approve the consultants share option plan 2008

 

For

 

Yes

 

Against

 

Management

9

 

To increase the authorised share capital

 

For

 

Yes

 

Against

 

Management

10

 

To approve the capitalisation and bonus issue

 

For

 

Yes

 

For

 

Management

11

 

To authorise the company to allot shares

 

For

 

Yes

 

For

 

Management

12

 

To disapply the statutory pre-emption rights

 

For

 

Yes

 

For

 

Management

13

 

To authorise the company to make market purchases of shares

 

For

 

Yes

 

For

 

Management

14

 

To authorise the chairman to have a casting vote such other business as may come before the meeting

 

For

 

Yes

 

For

 

Management

 

16


 

45168D104

 

IDXX

IDEXX Laboratories, Inc.

 

 

Meeting Date:

5/6/2009

 

Meeting Type:

Annual

Record Date:

3/9/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director William T. End

 

For

 

Yes

 

For

 

Management

1

 

Elect director Barry C. Johnson, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Brian P. McKeon

 

For

 

Yes

 

For

 

Management

2

 

Adoption of the IDEXX Laboratories, Inc. 2009 stock incentive plan to approve and adopt the 2009 stock incentive plan

 

For

 

Yes

 

For

 

Management

3

 

Amendment to the IDEXX Laboratories, Inc. 1997 employee stock purchase plan to approve and adopt a proposed amendment to our 1997 employee stock purchase plan to increase the number of shares authorized for issuance under the plan from 1,240,000 shares to 1,590,000 shares

 

For

 

Yes

 

For

 

Management

4

 

To ratify the selection by the audit committee of the board of directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the current fiscal year

 

For

 

Yes

 

For

 

Management

5

 

To conduct such other business as may properly come before the annual meeting

 

For

 

Yes

 

For

 

Management

 

452327109

 

ILMN

Illumina, Inc.

 

 

Meeting Date:

5/8/2009

 

Meeting Type:

Annual

Record Date:

3/16/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director A. Blaine Bowman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Karin Eastham

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jay T. Flatley

 

For

 

Yes

 

For

 

Management

1

 

Elect director William H. Rastetter

 

For

 

Yes

 

For

 

Management

2

 

Ratify the appointment of Ernst & Young LLP as independent auditors

 

For

 

Yes

 

For

 

Management

 

46120E602

 

ISRG

Intuitive Surgical, Inc.

 

 

Meeting Date:

4/22/2009

 

Meeting Type:

Annual

Record Date:

2/27/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Gary S. Guthart

 

Yes

 

Yes

 

For

 

Management

1

 

Elect director Mark J. Rubash

 

Yes

 

Yes

 

For

 

Management

1

 

Elect director Lonnie M. Smith

 

Yes

 

Yes

 

For

 

Management

 

17


 

46126P106

 

IMA

Inverness Medical Innovations, Inc.

 

 

Meeting Date:

6/18/2009

 

Meeting Type:

Annual

Record Date:

4/27/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Carol R. Goldberg

 

For

 

Yes

 

For

 

Management

1

 

Elect director James Roosevelt, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ron Zwanziger

 

For

 

Yes

 

For

 

Management

2

 

Approval of an increase to the number of shares of common stock available for issuance under the Inverness Medical Innovations, Inc. 2001 stock option and incentive plan by 1,000,000 from 11,074,081 to 12,074,081

 

For

 

Yes

 

For

 

Management

3

 

Approval of an increase to the number of shares of common stock available for issuance under the Inverness Medical Innovations, Inc. 2001 employee stock purchase plan by 1,000,000 from 1,000,000 to 2,000,000

 

For

 

Yes

 

For

 

Management

4

 

Ratification of the appointment of BDO Seidman, LLP as the independent registered public accountants for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

50540R409

 

LH

Laboratory Corp. of America Holdings

 

Meeting Date:

5/6/2009

 

Meeting Type:

Annual

Record Date:

3/13/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Thomas P. MacMahon

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kerrii B. Anderson

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jean-Luc Belingard

 

For

 

Yes

 

For

 

Management

1

 

Elect director David P. King

 

For

 

Yes

 

For

 

Management

1

 

Elect director Wendy E. Lane

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert E. Mittelstaedt, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Arthur H. Rubenstein, Mbbch

 

For

 

Yes

 

For

 

Management

1

 

Elect director M. Keith Weikel, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director R. Sanders Williams, MD

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for 2009

 

For

 

Yes

 

For

 

Management

 

528872104

 

LXRX

Lexicon Pharmaceuticals, Inc.

 

 

Meeting Date:

4/23/2009

 

Meeting Type:

Annual

Record Date:

2/23/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Arthur T. Sands, MD, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Philippe J. Amouyal

 

For

 

Yes

 

For

 

Management

1

 

Elect director Frank P. Palantoni

 

For

 

Yes

 

For

 

Management

2

 

Approval of the company’s equity incentive plan, amending and restating the company’s existing 2000 equity incentive plan

 

For

 

Yes

 

Against

 

Management

3

 

Approval of the company’s non-employee directors’ stock option plan, amending and restating the company’s existing 2000 non-employee directors’ stock option plan

 

For

 

Yes

 

Against

 

Management

4

 

Ratification and approval of the appointment of Ernst & Young LLP as the company’s independent auditors for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

18


 

53217V109

 

LIFE

Life Technologies Corporation

 

 

Meeting Date:

4/30/2009

 

Meeting Type:

Annual

Record Date:

2/27/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Donald W. Grimm

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gregory T. Lucier

 

For

 

Yes

 

For

 

Management

1

 

Elect director Per A. Peterson, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director William S. Shanahan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Arnold J. Levine, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the apointment of Ernst & Young LLP as independent auditors of the company for fiscal year 2009

 

For

 

Yes

 

For

 

Management

3

 

Amendment of Invitrogen Corporation 1998 employee stock purchase plan

 

For

 

Yes

 

Against

 

Management

4

 

Adoption of Life Technologies Corporation 1999 employee stock purchase plan

 

For

 

Yes

 

For

 

Management

5

 

Adoption of the company’s 2009 equity incentive plan

 

For

 

Yes

 

Against

 

Management

 

N/A

 

N/A

Magellan Biosciences, Inc.

 

 

Action by Written Consent:

4/2/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of amendment and restatement of the company’s amended and restated certificate

 

For

 

Yes

 

For

 

Management

2

 

Approval of financing

 

For

 

Yes

 

For

 

Management

3

 

Approval of warrants

 

For

 

Yes

 

For

 

Management

 

572901106

 

MATK

Martek Biosciences Corporation

 

 

Meeting Date:

3/19/2009

 

Meeting Type:

Annual

Record Date:

1/21/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Harry J. D’Andrea

 

For

 

Yes

 

For

 

Management

1

 

Elect director James R. Beery

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael G. Devine

 

For

 

Yes

 

For

 

Management

1

 

Elect director Steve Dubin

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Flanagan

 

For

 

Yes

 

For

 

Management

1

 

Elect director Polly B. Kawalek

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jerome C. Keller

 

For

 

Yes

 

For

 

Management

1

 

Elect director Douglas J. Macmaster, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert H. Mayer

 

For

 

Yes

 

For

 

Management

1

 

Elect director Eugene H. Rotberg

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year 2009

 

For

 

Yes

 

For

 

Management

 

19


 

574795100

 

MASI

Masimo Corporation

 

 

Meeting Date:

6/16/2009

 

Meeting Type:

Annual

Record Date:

4/24/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Edward L. Cahill

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert Coleman, Ph.D.

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection of Grant Thornton LLP as the company’s independent auditors for fiscal year 2009

 

For

 

Yes

 

For

 

Management

 

58405U102

 

MHS

Medco Health Solutions, Inc.

 

 

Meeting Date:

5/21/2009

 

Meeting Type:

Annual

Record Date:

3/26/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Charles M. Lillis

 

For

 

Yes

 

For

 

Management

1

 

Elect director William L. Roper

 

For

 

Yes

 

For

 

Management

1

 

Elect director David D. Stevens

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the company for the 2009 fiscal year

 

For

 

Yes

 

For

 

Management

3

 

Approval of executive annual incentive plan

 

For

 

Yes

 

For

 

Management

 

584688105

 

MDCO

Medicines Company

 

 

Meeting Date:

5/28/2009

 

Meeting Type:

Annual

Record Date:

4/3/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Armin M. Kessler

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert G. Savage

 

For

 

Yes

 

For

 

Management

1

 

Elect director Melvin K. Spigelman

 

For

 

Yes

 

For

 

Management

2

 

Approve an amendment to the company’s 2000 employee stock purchase plan to increase the number of shares of common stock authorized for issuance under the plan from 505,000 shares to 805,500 shares

 

For

 

Yes

 

Against

 

Management

3

 

Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

20


 

628530107

 

MYL

Mylan, Inc.

 

 

Meeting Date:

5/7/2009

 

Meeting Type:

Annual

Record Date:

3/20/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Milan Puskar

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert J. Coury

 

For

 

Yes

 

For

 

Management

1

 

Elect director Wendy Cameron

 

For

 

Yes

 

For

 

Management

1

 

Elect director Neil Dimick, CPA

 

For

 

Yes

 

For

 

Management

1

 

Elect director Doug Leech, CPA

 

For

 

Yes

 

For

 

Management

1

 

Elect director Joseph C. Maroon, MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director Rodney L. Piatt, CPA

 

For

 

Yes

 

For

 

Management

1

 

Elect director C.B. Todd

 

For

 

Yes

 

For

 

Management

1

 

Elect director R.L. Vanderveen, Ph.D. R.Ph.

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment to the company’s articles of incorporation to increase authorized shares

 

For

 

Yes

 

For

 

Management

3

 

Approve an amendment to the company’s 2003 long-term incentive plan

 

For

 

Yes

 

For

 

Management

4

 

Approve an amendment to the company’s bylaws regarding voting in uncontested director elections

 

For

 

Yes

 

For

 

Management

5

 

Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm

 

For

 

Yes

 

For

 

Management

 

62555J104

 

MYGN

Myriad Genetics, Inc.

 

 

Meeting Date:

11/13/2008

 

Meeting Type:

Annual

Record Date:

9/26/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Walter Gilbert, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director D.H. Langer, MD, J.D.

 

For

 

Yes

 

For

 

Management

2

 

Proposal to amend the restated certificate of incorporation, as amended, to increase the number of authorized common stock from 60,000,000 shares to 150,000,000 shares

 

For

 

Yes

 

For

 

Management

3

 

Proposal to amend the 2003 employee, director and consutant stock option plan to increase the number of shares of common stock available for issuance thereunder by 1,500,000 shares

 

For

 

Yes

 

Against

 

Management

4

 

Proposal to ratify the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending June 30, 2009

 

For

 

Yes

 

For

 

Management

 

21


 

654798503

 

NTMD

Nitromed, Inc.

 

 

Meeting Date:

4/22/2009

 

Meeting Type:

Special

Record Date:

3/6/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Agreement and plan of merger, by and among Deerfield Private Design Fund, L.P., Deerfield Private Design International, L.P., Deerfield Special Situations Fund, L.P., Deerfield Special Situations Fund International Limited, NTMD Parent Acquisition Corp., NTMD Acquisition Corp. and Nitromed, a copy of which is attached as annex A to the accompanying proxy statement

 

For

 

Yes

 

For

 

Management

2

 

To approve an adjournment of the Nitromed special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of proposal No. 1

 

For

 

Yes

 

For

 

Management

 

654798503

 

NTMD

Nitromed, Inc.

 

 

Meeting Date:

1/27/2009

 

Meeting Type:

Special

Record Date:

12/11/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the sale of substantially all of Nitromed’s assets pursuant to the purchase and sale agreement, dated October 22, 2008, by and between Nitromed and JHP Pharmaceuticals, LLC, a copy of which is attached as Annex A to the accompanying proxy statement.

 

For

 

Yes

 

For

 

Management

2

 

To approve an adjournment of the Nitromed special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of proposal No. 1

 

For

 

Yes

 

For

 

Management

 

671040109

 

OSIP

OSI Pharmaceuticals, Inc.

 

 

Meeting Date:

6/17/2009

 

Meeting Type:

Annual

Record Date:

4/22/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Robert A. Ingram

 

For

 

Yes

 

For

 

Management

1

 

Elect director Colin Goddard, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Santo J. Costa

 

For

 

Yes

 

For

 

Management

1

 

Elect director Joseph Klein, III

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kenneth B. Lee, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Viren Mehta

 

For

 

Yes

 

For

 

Management

1

 

Elect director David W. Niemiec

 

For

 

Yes

 

For

 

Management

1

 

Elect director H.M. Pinedo, MD, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Katharine B. Stevenson

 

For

 

Yes

 

For

 

Management

1

 

Elect director John P. White

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the appointment of KPMG LLP as the independent registered public accounting firm of the corporation for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

22


 

709754105

 

PPCO

Penwest Pharmaceuticals Co.

 

 

Meeting Date:

6/10/2009

 

Meeting Type:

Annual - Contested

Record Date:

4/7/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Kevin C. Tang

 

Unknown

 

Yes

 

For

 

Opposition

1

 

Elect director Joseph Edelman

 

Unknown

 

Yes

 

For

 

Opposition

1

 

Elect directo Andrew D. Levin, MD, Ph.D.

 

Unknown

 

Yes

 

For

 

Opposition

2

 

To approve the proposed amendment to the company’s bylaws to set the date of all future annual meetings of shareholders on April 30th or the following business day

 

Against

 

Yes

 

For

 

Opposition

3

 

To approve the proposed amendment to the company’s bylaws to require the approval of 75% of the directors in office to various specified actions

 

Against

 

Yes

 

For

 

Opposition

3

 

To approve the proposed amendment to the company’s bylaws to require the approval of 81% of the directors in office to various specified actions

 

Against

 

Yes

 

For

 

Opposition

4

 

To approve the following shareholder resolution: Now, therefore, be it resolved, that the shareholders of the company hereby request that the Board of Directors of the company take prompt and thoughtful action to preserve shareholder value by immediately winding down substantially all of the company’s operations so that the full value of the Opana ER royalty income stream will be retained for the benefit of shareholders

 

Against

 

Yes

 

For

 

Stockholder

5

 

To ratify the appointment of Ernst & Young LLP as independent public accountants of the company for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Opposition

6

 

To approve the proposed amendment to the company’s 1997 stock purchase plan

 

For

 

Yes

 

For

 

Opposition

 

709754105

 

PPCO

Penwest Pharmaceuticals Co.

 

 

Meeting Date:

6/10/2009

 

Meeting Type:

Annual - Contested

Record Date:

4/7/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

 

1

 

Elect director W. James O’Shea

 

For

 

No

 

None

 

Management

 

1

 

Elect director Joseph Edelman

 

For

 

No

 

None

 

Management

 

2

 

Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the current fiscal year

 

For

 

No

 

None

 

Management

 

3

 

Approval of the proposed amendment to the Company’s 1997 employee stock purchase plan

 

For

 

No

 

None

 

Management

 

 

23


 

714046109

 

PKI

PerkinElmer, Inc.

 

 

Meeting Date:

4/28/2009

 

Meeting Type:

Annual

Record Date:

3/2/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Robert F. Friel

 

For

 

Yes

 

For

 

Management

1

 

Elect director Nicholas A. Lopardo

 

For

 

Yes

 

For

 

Management

1

 

Elect director Alexis P. Michas

 

For

 

Yes

 

For

 

Management

1

 

Elect director James C. Mullen

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dr. Vicki L. Sato

 

For

 

Yes

 

For

 

Management

1

 

Elect director Gabriel Schmergel

 

For

 

Yes

 

For

 

Management

1

 

Elect director Kenton J. Sicchitano

 

For

 

Yes

 

For

 

Management

1

 

Elect director Patrick J. Sullivan

 

For

 

Yes

 

For

 

Management

1

 

Elect director G. Robert Tod

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Deloitte & Touche LLP as Perkinelmer’s independent auditors for the current fiscal year

 

For

 

Yes

 

For

 

Management

3

 

To approve the Perkinelmer, Inc. 2009 incentive plan

 

For

 

Yes

 

For

 

Management

 

717081103

 

PFE

Pfizer, Inc.

 

 

Meeting Date:

4/23/2009

 

Meeting Type:

Annual

Record Date:

2/24/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Dennis A. Ausiello

 

For

 

Yes

 

For

 

Management

1

 

Elect director Michael S. Brown

 

For

 

Yes

 

For

 

Management

1

 

Elect director M. Anthony Burns

 

For

 

Yes

 

For

 

Management

1

 

Elect director Robert N. Burt

 

For

 

Yes

 

For

 

Management

1

 

Elect director W. Don Cornwell

 

For

 

Yes

 

For

 

Management

1

 

Elect director William H. Gray, III

 

For

 

Yes

 

For

 

Management

1

 

Elect director Constance J. Horner

 

For

 

Yes

 

For

 

Management

1

 

Elect director James M. Kilts

 

For

 

Yes

 

For

 

Management

1

 

Elect director Jeffrey B. Kindler

 

For

 

Yes

 

For

 

Management

1

 

Elect director George A. Lorch

 

For

 

Yes

 

For

 

Management

1

 

Elect director Dana G. Mead

 

For

 

Yes

 

For

 

Management

1

 

Elect director Suzanne Nora Johnson

 

For

 

Yes

 

For

 

Management

1

 

Elect director Stephen W. Sanger

 

For

 

Yes

 

For

 

Management

1

 

Elect director William C. Steere, Jr.

 

For

 

Yes

 

For

 

Management

2

 

Proposal to ratify the selection of KPMG LLP as independent registered public accounting firm for 2009

 

For

 

Yes

 

For

 

Management

3

 

Proposal to approve the Pfizer Inc. 2004 stock plan, as amended and restated

 

For

 

Yes

 

For

 

Management

4

 

Shareholder proposal regarding stock options

 

Against

 

Yes

 

Against

 

Stockholder

5

 

Shareholder proposal regarding advisory vote on executive compensation

 

Against

 

Yes

 

Against

 

Stockholder

6

 

Shareholder proposal regarding cumulative voting

 

Against

 

Yes

 

Against

 

Stockholder

7

 

Shareholder proposal regarding special shareholder meetings

 

Against

 

Yes

 

Against

 

Stockholder

 

24


 

717124101

 

PPDI

Pharmaceutical Product Development, Inc.

 

Meeting Date:

5/20/2009

 

Meeting Type:

Annual

Record Date:

3/20/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Stuart Bondurant, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Frederic N. Eshelman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Frederick Frank

 

For

 

Yes

 

For

 

Management

1

 

Elect director General David L. Grange

 

For

 

Yes

 

For

 

Management

1

 

Elect director Catherine M. Klema

 

For

 

Yes

 

For

 

Management

1

 

Elect director Terry Magnuson, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ernest Mario, Ph.D.

 

For

 

Yes

 

For

 

Management

1

 

Elect director John A. McNeill, Jr.

 

For

 

Yes

 

For

 

Management

2

 

To approve an amendment and restatement of the company’s 1995 equity compensation plan which, among other things, increases the number of shares of our common stock reserved for issuance under the plan by 8,300,000 from 21,259,004 shares to 29,559,004 shares

 

For

 

Yes

 

For

 

Management

3

 

Ratification of the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

4

 

In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the meeting

 

For

 

Yes

 

Abstain

 

Management

 

863667101

 

SYK

Stryker Corporation

 

Meeting Date:

4/29/2009

 

Meeting Type:

Annual

Record Date:

3/2/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director John W. Brown

 

For

 

Yes

 

For

 

Management

1

 

Elect director Howard E. Cox, Jr.

 

For

 

Yes

 

For

 

Management

1

 

Elect director Donald M. Engelman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Louise L. Francesconi

 

For

 

Yes

 

For

 

Management

1

 

Elect director Howard L. Lance

 

For

 

Yes

 

For

 

Management

1

 

Elect director Stephen P. Macmillan

 

For

 

Yes

 

For

 

Management

1

 

Elect director William U. Parfet

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ronda E. Stryker

 

For

 

Yes

 

For

 

Management

2

 

Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2009

 

For

 

Yes

 

For

 

Management

 

25


 

N/A

 

N/A

Syntiro Healthcare Services

 

Action by Written Consent:

6/8/2009

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of restated charter of the corporation

 

For

 

No

 

None

 

Management

2

 

Authorization of officers to execute the actions in forgoing resolution

 

For

 

No

 

None

 

Management

3

 

Approval of actions taken by officers with regard to transaction in forgoing resolution

 

For

 

No

 

None

 

Management

 

881624209

 

TEVA

Teva Pharmaceutical Industries Ltd.

 

Meeting Date:

9/25/2008

 

Meeting Type:

Special

Record Date:

8/18/2008

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To appoint Joseph Nitzani as a statutory independent director for a term of three years

 

For

 

Yes

 

For

 

Management

 

881624209

 

TEVA

Teva Pharmaceutical Industries Ltd.

 

Meeting Date:

6/22/2009

 

Meeting Type:

Annual

Record Date:

5/13/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

To approve the board of directors’ recommendation that the cash dividend for year ended December 31, 2008, which was paid in four installments and aggregated NIS 1.95 (approximately $0.525, according to the applicable exchange rates) per ordinary share (or ADS), be delcared final

 

For

 

Yes

 

For

 

Management

2

 

Elect director Dr. Phillip Frost

 

For

 

Yes

 

For

 

Management

2

 

Elect director Roger Abravanel

 

For

 

Yes

 

For

 

Management

2

 

Elect director Prof. Elon Kohlberg

 

For

 

Yes

 

For

 

Management

2

 

Elect director Prof. Yitzhak Peterburg

 

For

 

Yes

 

For

 

Management

3

 

Elect director Erez Vigoman

 

For

 

Yes

 

For

 

Management

4

 

To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as the company’s independent registered public accounting firm until the 2010 annual meeting of shareholders and to authorize the board to determine their compensation provided such compensation is also approved by the audit committee

 

For

 

Yes

 

For

 

Management

 

26


 

N/A

 

N/A

Therox, Inc.

 

Action by Written Consent:

1/8/2009

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Increase shares issuable under stock incentive plan

 

For

 

Yes

 

For

 

Management

2

 

Approval of amendment to and restated certificate of incorporation

 

For

 

Yes

 

For

 

Management

3

 

Approval of amendment to third amended and restated investors’ rights and voting agreement

 

For

 

Yes

 

For

 

Management

4

 

Omnibus resolutions

 

For

 

Yes

 

For

 

Management

 

91307C102

 

UTHR

United Therapeutics Corporation

 

Meeting Date:

6/26/2009

 

Meeting Type:

Annual

Record Date:

4/29/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Ray Kurzweil

 

For

 

Yes

 

For

 

Management

1

 

Elect director Martine Rothblatt

 

For

 

Yes

 

For

 

Management

1

 

Elect director Louis Sullivan

 

For

 

Yes

 

For

 

Management

2

 

Vote to ratify Ernst & Young LLP as United Therapeutics Corporation’s independent registered public accounting firm for 2009

 

For

 

Yes

 

For

 

Management

 

92532F100

 

VRTX

Vertex Pharmaceuticals Incorporated

 

Meeting Date:

5/14/2009

 

Meeting Type:

Annual

Record Date:

3/17/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Roger W. Brimblecombe

 

For

 

Yes

 

For

 

Management

1

 

Elect director Bruce I. Sachs

 

For

 

Yes

 

For

 

Management

2

 

The approval of the amendments to the amended and restated 2006 stock and option plan that increase the number of shares of common stock authorized for issuance under the plan by 7,700,000 shares from 13,902,380 shares to 21,602,380 shares and increase the maximum number of shares a participant may receive in a calendar year under the plan from 600,000 to 700,000

 

For

 

Yes

 

For

 

Management

3

 

The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

27


 

94973V107

 

WLP

WellPoint, Inc.

 

Meeting Date:

5/20/2009

 

Meeting Type:

Annual

Record Date:

3/18/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Lenox D. Baker, Jr., MD

 

For

 

Yes

 

For

 

Management

1

 

Elect director Susan B. Bayh

 

For

 

Yes

 

For

 

Management

1

 

Elect director Larry C. Glasscock

 

For

 

Yes

 

For

 

Management

1

 

Elect director Julie A. Hill

 

For

 

Yes

 

For

 

Management

1

 

Elect director Ramiro G. Peru

 

For

 

Yes

 

For

 

Management

2

 

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the company for 2009

 

For

 

Yes

 

For

 

Management

3

 

To approve the proposed WellPoint incentive compensation plan

 

For

 

Yes

 

For

 

Management

4

 

To approve the WellPoint employee stock purchase plan

 

For

 

Yes

 

For

 

Management

5

 

To consider a shareholder proposal concerning an advisory resolution on compensation of named executive officers if properly presented at the meeting

 

Against

 

Yes

 

For

 

Stockholder

 

98411C100

 

XNPT

Xenoport, Inc.

 

Meeting Date:

5/7/2009

 

Meeting Type:

Annual

Record Date:

3/20/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Catherine J. Friedman

 

For

 

Yes

 

For

 

Management

1

 

Elect director Per G.H. Lofberg

 

For

 

Yes

 

For

 

Management

2

 

To ratify the selection by the Audit Committee of the board of directors of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2009

 

For

 

Yes

 

For

 

Management

 

N/A

 

N/A

Xoft, Inc.

 

Action by Written Consent:

6/11/2009

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Approval of note and warrant financing

 

For

 

Yes

 

For

 

Management

2

 

Approval of amended and restated certificate of incorporation

 

For

 

Yes

 

For

 

Management

3

 

Approval of conversion of preferred stock

 

For

 

Yes

 

For

 

Management

4

 

Approval of waiver of right of first refusal

 

For

 

Yes

 

For

 

Management

5

 

Approval of indemnification agreements

 

For

 

Yes

 

For

 

Management

6

 

Omnibus resolutions

 

For

 

Yes

 

For

 

Management

 

98974P100

 

ZIXI

Zix Corporation

 

Meeting Date:

6/4/2009

 

Meeting Type:

Annual

Record Date:

4/14/2009

 

 

 

 

#

 

Proposal

 

Mgt. Recommends

 

Voted

 

Vote Cast

 

Sponsor

1

 

Elect director Robert C. Hausmann

 

For

 

Yes

 

For

 

Management

1

 

Elect director Charles N. Kahn III

 

For

 

Yes

 

For

 

Management

1

 

Elect director James S. Marston

 

For

 

Yes

 

For

 

Management

1

 

Elect director Antonio R. Sanchez III

 

For

 

Yes

 

For

 

Management

1

 

Elect director Paul E. Schlosberg

 

For

 

Yes

 

For

 

Management

1

 

Elect director Richard D. Spurr

 

For

 

Yes

 

For

 

Management

2

 

A proposal to ratify the selection of Whitley Penn LLP as our independent registered public accountants

 

For

 

Yes

 

For

 

Management

 

28


 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

H&Q Life Sciences Investors

 

By (Signature and Title)*

 

 

 

 

(Daniel Omstead, President)

 

/s/ Daniel Omstead

 

Date

8/31/09

 

*Print the name and title of each signing officer under his or her signature.

 

2